News

2015 WGND Annual Meeting and Reception


22 Nov 2015
by Working Group

Cape Town, South Africa, Dec. 5, 17:30 – 20:30

We invite you to join us for the Stop TB Partnership Working Group on New Drugs’ Annual Meeting 2015 at Southern Sun Cape Sun Hotel, Cape Town, South Africa, on Saturday, Dec. 5th from 17:30 to 20:30.

This meeting is held before the 46th Union World Conference on Lung Health (The Union). During the meeting we will review and discuss progress of projects in the Global TB Drug Pipeline and Drug Discovery Portfolio, the new Global Plan, review WGND 2015 activities, and discuss other relevant topics. Representatives from pharmaceutical companies, research consortia and organizations, NGOs and academia will be participating.

2015 WGND ANNUAL MEETING

Agenda

17:30 – 17:35

Welcome Mel Spigelman

17:35 – 17:40

Stop TB Partnership, Global Plan Cherise Scott

17:40 – 17:50

TB Drug Development Year-in-Review Barbara Laughon
Global Pipeline Update

17:50 – 18:00

Janssen Myriam Haxaire

18:05 – 18:15

Clinical Trials Unit, MRC Andrew Nunn

18:20 – 18:30

TB Alliance Christo van Niekerk

18:35 – 18:45

AIDS Clinical Trials Group (ACTG) Susan Swindells

18:50 – 19:00

NIAID – Host-Directed Therapy Richard Hafner

19:05 – 19:15

University of Munich / EDCTP/PanACEA Michael Hoelscher & Martin Boeree

19:20 – 19:30

TB Trials Consortium (CDC) Neil Schluger
Looking Forward

19:35 – 19:50

Discussion of STOP TB Partnership Association Mel Spigelman, Cherise Scott, Barbara Laughon

19:50 – 20:30

Cocktail Reception WGND Members

Saturday, December 5th, 2015 | 17:30 – 20:30

Southern Sun Cape Sun Hotel| Cape Town, South Africa

Heavy hors d’oeuvres and drinks will be served.

Registration is free.

Please register by sending an e-mail reply to wgnd@newtbdrugs.org.

If you have any questions, please feel free to contact me.

Explore. Learn. Join the Conversation at www.newtbdrugs.org.
Best regards,

Cherise Scott, WGND Secretariat

More News
22 Jul 2024
The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) has issued a $30.8 million grant to the Preclinical Design and Clinical Translation of TB Regimens (PreDiCTR) consortium , a new consortium co-led by investigators from Weill Cornell Medicine; the...
27 Jun 2024
On May 17, the World Health Organization (WHO) released its updated  Bacterial Priority Pathogens List (BPPL) 2024 and for the first time in its history it included a drug resistant strain of Mycobacterium tuberculosis. Along with three other new families of antibiotic-resistant bacterial pathogens...
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...